MAXIMUM CREDIT VALUE. Patheon’s liability for Active Material calculated in accordance with Section 2.2 in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE BC-3781 [**]% of revenues (being payments of the Price) per Year received by Patheon under this Agreement. SCHEDULE E
Appears in 1 contract
Samples: Manufacturing Services Agreement (Nabriva Therapeutics PLC)
MAXIMUM CREDIT VALUE. Patheon’s 's liability for Active Material Materials calculated in accordance with Section 2.2 of the Master Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE BC-3781 10mg CCX-168 Capsules [**]% *] of revenues (being payments of the Price) per Year received by to Patheon under this Product Agreement. SCHEDULE E.
Appears in 1 contract
MAXIMUM CREDIT VALUE. Patheon’s liability for Active Material Materials calculated in accordance with Section 2.2 of the Master Agreement for the Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE BC-3781 Crofelemer [**]*] % of revenues (being payments of the Price) per Year received by to Patheon under this Product Agreement, up to a maximum of $[***] in the aggregate per Year. SCHEDULE E[End of Product Agreement] *** Confidential Treatment Requested
Appears in 1 contract
MAXIMUM CREDIT VALUE. Patheon’s 's liability for Active Material Materials calculated in accordance with Section 2.2 of the Master Agreement for the Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE BC-3781 Varubi [***]% of revenues (being payments of the Price) per Year received by Patheon under this Agreement. SCHEDULE E
Appears in 1 contract
Samples: Product Agreement (TESARO, Inc.)